CRISPR-Cas9 and Optogenetics Converge

Japanese researchers led by University of Tokyo chemist Moritoshi Sato have refined the CRISPR-Cas9 method by developing a light-activated Cas9 nuclease, a technological advancement that significantly improves scientists’ ability to hone in on target genes for research. Converging these two methods brings specificity on a new level, making for increased spatial and temporal control over…

CRISPR CasMINE

Imagine if somebody patented the book. Or a nut-and-bolt. This is how Tony Fong of Genome Web Daily news would compare the patenting the CRISPR-Cas9 gene editing technology, recently awarded to the Broad Institute. In the same way that any modern mechanics would be impossible without the use of basic tools, the future of cost-effective…